Hepatitis C virus and other risk factors in hepatocellular carcinoma

Acta Virologica

Volumn 56, Issue 3, 2012, Pages 235-240

  Schiefelbein, E ^a   Zekri, A R ^b   Newton, D W ^a   Soliman, G A ^d   Banerjee, M ^a   Hung, C H W ^a   Seifeldin, I A ^c   Lo, A C H ^a   Soliman, A S ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (Egypt)

^c Gharbiah Cancer Registry   (Egypt)

^d WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

Egypt; Hepatitis; Hepatocellular carcinoma; Risk factors; Rural

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CANCER RISK; CONTROLLED STUDY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; POLYMERASE CHAIN REACTION; RURAL AREA; SCHISTOSOMIASIS; CASE CONTROL STUDY; GENETICS; ISOLATION AND PURIFICATION; LIVER TUMOR; MIDDLE AGED; RISK FACTOR; VIROLOGY;

ADOLESCENT; ADULT; AGED; BLOOD TRANSFUSION; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; EGYPT; HEPACIVIRUS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84873510486     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2012_03_235     Document Type: Article

References (29)

1. Abdel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, Thomas D, Fix AD, Strickland GT, Anwar W, Sallam I (2000): Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 32, 111-115. http://dx.doi.org/10.1053/jhep.2000.8438
2. Abdel-Wahab M, El-Enein AA, Abou-Zeid M, El-Fiky A, Abdallah T, Fawzy M, Fouad A, Sultan A, Fathy O, El-Ebidy G, elghawalby N, Ezzat F (2000): Hepatocellular carcinoma in Mansoura-Egypt: experience of 385 patients at a single center. Hepatogastroenterology 47, 663-668.
3. Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA (2008): Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res. 659, 176-184. http://dx.doi.org/10.1016/j.mrrev.2008.01.005
4. Bosch FX, Ribes J, Diaz M, Cleries R (2004): Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 (Suppl. 1), S5-S16. http://dx.doi.org/10.1053/j.gastro.2004.09.011
5. Bouchard MJ, Navas-Martin S (2011): Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett. 305, 123-143. http://dx.doi.org/10.1016/j.canlet.2010.11.014
6. Boyle P, Levin B (Eds) (2008): World Cancer Report 2008. International Agency for Research on Cancer (IARC) Lyon, France.
7. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P (2001): Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 34, 194-203.
8. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G (1999): Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N. Engl. J. Med. 341, 22-26. http://dx.doi.org/10.1056/NEJM199907013410104
9. Darwish MA, Faris R, Darwish N, Shouman A, Gadallah M, El-Sharkawy MS, Edelman R, Grumbach K, Rao MR, Clemens JD (2001): Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study. Am. J. Trop. Med. Hyg. 64, 147-153.
10. El-Sadawy M, Ragab H, El-Toukhy H, El-Mor A, Mangoud AM, Eissa MH, Afefy AF, El-Shorbagy E, Ibrahem IA, Mahrous S, Abdel-Monem A, Sabee EI, Ismail A, Morsy TA, Etewa S, Nor Edin E, Mostafa Y, Abouel-Magd Y, Hassan MI, Lakouz K, Abdel-Aziz K, El-Hady G, Saber M (2004): Hepatitis C virus infection at Sharkia Governorate, Egypt: seroprevalence and associated risk factors. J. Egypt Soc. Parasitol. 34 (1 Suppl.), 367-384.
11. El-Sherif A, Abou-Shady M, Abou-Zeid H, Elwassief A, Elbahrawy A, Ueda Y, Chiba T, Hosney AM (2009): Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients. J. Gastroenterol. 44, 359-364. http://dx.doi.org/10.1007/s00535-009-0020-3
12. El-Zayadi AR, Badran HM, Barakat EM, Attia M, Shawky S, Mohamed MK, Selim O, Saeid A (2005): Hepatocellular carcinoma in Egypt: a single center study over a decade. World J. Gastroenterol. 11, 5193-5198.
13. Ezzat S, Abdel-Hamid M, Eissa SA, Mokhtar N, Labib NA, El-Ghorory L, Mikhail NN, Abdel-Hamid A, Hifnawy T, Strickland GT, Loffredo CA (2005): Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int. J. Hyg. Environ. Health 208, 329-339. http://dx.doi.org/10.1016/j.ijheh.2005.04.003
14. Franceschi S, Raza SA (2009): Epidemiology and prevention of hepatocellular carcinoma. Cancer Lett. 286, 5-8. http://dx.doi.org/10.1016/j.canlet.2008.10.046
15. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I (2000): The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355, 887-891. http://dx.doi.org/10.1016/S0140-6736(99)06527-7
16. Hassan MM, Zaghloul AS, El-Serag HB, Soliman O, Patt YZ, Chappell CL, Beasley RP, Hwang LY (2001): The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J. Clin. Gastroenterol. 33, 123-126. http://dx.doi.org/10.1097/00004836-200108000-00006
17. Hassan ZK, Hafez MM, Mansor TM, Zekri AR (2011): Occult HBV infection among Egyptian hepatocellular carcinoma patients. Virol. J. 8, 90. http://dx.doi.org/10.1186/1743-422X-8-90
18. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans & International Agency for Research on Cancer (1994): Hepatitis Viruses. International Agency for Research on Cancer, Lyon, France.
19. Ibrahim AS, Seif-Eldein IAB, Ismail K, Hablas A, Hussein H, Elhamzawy H, Ramadan M (Eds) (2007): Cancer in Egypt, Gharbiah: Triennial Report of 2000-2002, Gharbiah Population-Based Cancer Registry. Gharbiah Population-Based Cancer Registry, Tanta, Egypt.
20. Ibrahim SA, Abdelwahab SF, Mohamed MM, Osman AM, Fathy E, Al-Badry KS, Al-Kady N, Esmat GE, Al-Sherbiny MM (2006): T cells are depleted in HCV -induced hepatocellular carcinoma patients: possible role of apoptosis and p53. Egypt J. Immunol. 13, 11-22.
21. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009): Cancer statistics, 2009. CA Cancer J. Clin. 59, 225-249. http://dx.doi.org/10.3322/caac.20006
22. Lehman EM, Soliman AS, Ismail K, Hablas A, Seifeldin IA, Ramadan M, El-Hamzawy H, Shoushtari CS, Wilson ML (2008): Patterns of hepatocellular carcinoma incidence in Egypt from a population-based cancer registry. Hepatol. Res. 38, 465-473. http://dx.doi.org/10.1111/j.1872-034X.2007.00299.x
23. Lehman EM, Wilson ML (2009a): Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J. Viral Hepat. 16, 650-658. http://dx.doi.org/10.1111/j.1365-2893.2009.01115.x
24. Lehman EM, Wilson ML (2009b): Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis.Int. J. Cancer 124, 690-697. http://dx.doi.org/10.1002/ijc.23937
25. Parkin DM, Bray F, Ferlay J, Pisani P (2005): Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108. http://dx.doi.org/10.3322/canjclin.55.2.74
26. Shi Y, Wu YH, Wu W, Zhang WJ, Yang J, Chen Z (2012): Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis. Liver Int. 32, 231-240. http://dx.doi.org/10.1111/j.1478-3231.2011.02481.x
27. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, Amarapurkar D, Chen CH, Dou X, El Khayat H, Elshazly M, Esmat G, Guan R, Han KH, Koike K, Largen A, Mc-Caughan G, Mogawer S, Monis A, Nawaz A, Piratvisuth T, Sanai FM, Sharara AI, Sibbel S, Sood A, Suh DJ, Wallace C, Young K, Negro F (2011): A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 31 (Suppl. 2), 61-80. http://dx.doi.org/10.1111/j.1478-3231.2011.02540.x
28. Soliman AS, Hung CW, Tsodikov A, Seifeldin IA, Ramadan M, Al-Gamal D, Schiefelbein EL, Thummalapally P, Dey S, Ismail K (2010): Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt. Hepatol. Int. 4, 681-690. http://dx.doi.org/10.1007/s12072-010-9187-1
29. Venook AP, Papandreou C, Furuse J, de Guevara LL (2010): The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15 (Suppl. 4), 5-13. http://dx.doi.org/10.1634/theoncologist.2010-S4-05